Recursion Pharma - Drug developer benefits from rising R&D expenditures in the pharmaceutical and biotech industry!
Reading Time: 1 minute
Business Driver: Recursion Pharma (RXRX) specializes in drug development with a focus on oncology, neurology, and rare diseases. Thanks to its "Tech-Bio Platform" solution, which allows for the recognition and analysis of changes in cell structures through drugs and medications using AI, it makes a valuable contribution to the development of new medications and active ingredients. Among its clients are pharmaceutical heavyweights like Roche/Genentech and Bayer. On September 11, Needham reiterated its rating of "Buy" with a price target of...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
